Mangoceuticals, Inc. (MGRX) Financials

$4.33

south_east
-$0.39 (-8.26%)
Day's range
$4.06
Day's range
$4.9
$2M$2M$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8M-$10M-$10MEarning2021202120222022202320230%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%-30000%-30000%Profit Margin
Profit Margin
Revenue
Earnings

MGRX Income statement / Annual

Last year (2023), Mangoceuticals, Inc.'s total revenue was $731,493.00, an increase of 8,083.16% from the previous year. In 2023, Mangoceuticals, Inc.'s net income was -$9.21 M. See Mangoceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021
Period Ended 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $731,493.00 $8,939.00 $0.00
Cost of Revenue $299,992.00 $4,089.00 $0.00
Gross Profit $431,501.00 $4,850.00 $0.00
Gross Profit Ratio 0.59 0.54 0
Research and Development Expenses $0.00 $0.00 $0.00
General & Administrative Expenses $6.45 M $2.00 M $70,080.00
Selling & Marketing Expenses $2.10 M $352,860.00 -$52,560.00
Selling, General & Administrative Expenses $8.55 M $2.00 M $17,520.00
Other Expenses $1.10 M $0.00 $0.00
Operating Expenses $9.65 M $2.00 M $17,520.00
Cost And Expenses $9.95 M $2.00 M $17,520.00
Interest Income $0.00 $0.00 $0.00
Interest Expense $0.00 $6,473.00 $181.00
Depreciation & Amortization $24,889.00 $3,863.00 $70,080.00
EBITDA -$9.19 M -$1.99 M $52,560.00
EBITDA Ratio -12.56 -222.36 0
Operating Income Ratio -12.6 -222.8 0
Total Other Income/Expenses Net $6,473.00 -$6,473.00 -$53,284.00
Income Before Tax -$9.21 M -$2.00 M -$17,701.00
Income Before Tax Ratio -12.59 -223.52 0
Income Tax Expense $0.00 -$224,622.00 -$70,080.00
Net Income -$9.21 M -$2.00 M -$17,701.00
Net Income Ratio -12.59 -223.52 0
EPS -6.45 -0.12 -0.001
EPS Diluted -6.45 -0.12 -0.001
Weighted Average Shares Out $1.43 M $17.32 M $17.32 M
Weighted Average Shares Out Diluted $1.43 M $17.32 M $17.32 M
Link